Clinical Trial Update: S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium [Phase 2]

View source ↗

Summary

Phase 2 trial update of S0121 evaluating neoadjuvant carboplatin, paclitaxel, and gemcitabine followed by cisplatin and radiation for locally advanced or recurr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urethral Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Bladder Cancer, Urethral Cancer | Phase 2 | Status: COMPLETED